- Home
- NG vs OPCH Comparison
NG vs OPCH Comparison
Compare NG & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NG | OPCH |
|---|---|---|
| Founded | 1984 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Nursing Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 2002 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NG | OPCH |
|---|---|---|
| Price | $6.39 | $21.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $12.22 | ★ $36.57 |
| AVG Volume (30 Days) | ★ 4.5M | 2.9M |
| Earning Date | 04-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | N/A | $7.21 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ N/A | $75.55 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $4.80 | $18.01 |
| 52 Week High | $14.40 | $36.80 |
Technical Indicators
Market Signals| Indicator | NG | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 40.06 | 53.20 |
| Support Level | N/A | $19.61 |
| Resistance Level | $10.61 | $22.42 |
| Average True Range (ATR) | 0.49 | 0.72 |
| MACD | -0.09 | 0.09 |
| Stochastic Oscillator | 18.54 | 67.24 |
Price Performance
Historical ComparisonAbout NG Novagold Resources Inc.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other precious metals.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.